Please assess the completion status of the following clinical trial:

Trial Title: Validation of [18F]FES for Imaging of Brain Estrogen Receptors

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female~* Age \> 18 years~* For postmenopausal women: at least 1 year after menopause~* For premenopausal women: a regular menstruation~* Signed written informed consent~Exclusion Criteria:~* Use of estrogen receptor ligands, such as tamoxifen or fulvestrant~* History of ER-positive malignancies or breast cancer~* Use of any contraceptive drugs (pill, injections or implanted)~* For postmenopausal women: (history of) estrogen replacement therapy~* Pregnancy~* History of removal of the ovaries and/or the uterus~* Current systemic diseases~* Major metabolic diseases (e.g. diabetes, hyper- or hypothyroidism)~* Somatic, organic or neurological disorders~* Recent participation in a scientific research study (\<1 year) involving radiation~* Claustrophobia~* Presence of materials in the body that can be magnetized, like: pacemaker, metallic implants/prostheses, metal fragments, shunts, artificial heart valves, vascular clips, fixed hearing aid, tattoos containing metal, hair implants, artificial dentures

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Premenopausal women (Type: OTHER): healthy female subjects: premenopausal
- Postmenopausal women (Type: OTHER): healthy female subjects: postmenopausal

Based on this trial design, predict the completion outcome and termination type (if applicable).